Groupe Berkem and Arctic Bioscience Collaborate on B-Romega™
Groupe Berkem is making significant strides in health innovation through its partnership with Arctic Bioscience. Together, they are introducing B-Romega™, a groundbreaking herring caviar oil extract set to make waves in the nutraceutical market. This unique formula, rich in phospholipid Omega-3, promises to deliver exceptional health benefits suitable for individuals at any life stage.
Innovation through Collaboration
This collaboration stems from Groupe Berkem’s strategic acquisition of Givaudan’s industrial site in Valencia, which previously involved Naturex Iberian Partners. Arctic Bioscience recognized a vital opportunity to leverage its expertise in marine extraction alongside Groupe Berkem’s extensive knowledge in phospholipids and Omega-3. Both organizations share a commitment to innovation and sustainability, which solidified their partnership.
Introducing B-Romega™: A Game-Changer in Nutrition
At the forefront of this partnership is B-Romega™, a novel product sourced from herring caviar, often referred to as the “silver fish” of the Nordic Sea. This roe oil extract offers a concentrated source of essential nutrients, specifically specialized pro-resolving mediators (SPM) and DHA-type phospholipids, known for their importance in supporting cellular health and effective anti-inflammatory responses. The extraction process used for B-Romega™ is both proprietary and sustainable, utilizing wild-caught herring that is certified by the Marine Stewardship Council (MSC).
The Health Benefits of B-Romega™
B-Romega™ is designed for lifelong supplementation, providing numerous health benefits that support heart, brain, eye, and even skin health. The unique composition of Omega-3 phospholipids in B-Romega™ enhances absorption in the body, compared to other Omega-3 sources, making it a highly beneficial addition for individuals aiming to maintain a healthy lifestyle.
Voices of Leadership in the Partnership
Amandine Brochot, Scientific Manager at Berkem, has expressed her excitement about this collaboration: “The alliance between Berkem and Arctic Bioscience marks a thrilling advancement in the Omega-3 supplement market. B-Romega™ leverages the natural advantages of phospholipid Omega-3 derived from herring caviar, ensuring superior bioavailability and significant health gains. By combining our strengths in marine extraction with scientific innovation, we are thrilled to offer a product that not only promotes health but also embodies our joint commitment to sustainability and forward-thinking research.”
Insights from Arctic Bioscience
Similarly, Kim Thorup, Executive Vice-President of Arctic Bioscience for B2B Nutra, shared her perspective: “From the outset, this collaboration felt natural. Partnering with Berkem as our sales and distribution ally in North America was a logical choice, given their expertise in ingredient manufacturing, ranging from raw material supply to production. The synergy between our teams presents an exciting opportunity for growth, and together, we are eager to bring something truly special to the North American B2B nutraceutical scene with B-Romega™.”
About Groupe Berkem
Founded in 1993 by Olivier Fahy, Groupe Berkem stands as a leader in the bio-based chemicals sector. Their mission is to promote environmental transition within companies that produce essential everyday chemicals, including those used in construction, health, beauty, and nutrition. With a focus on plant and marine extraction, Berkem develops bio-based solutions that enhance synthetic chemical performance. The company reported a revenue of €51.9 million recently and employs over 250 individuals across its facilities in locations including Blanquefort and Valencia.
About Arctic Bioscience
Arctic Bioscience specializes in developing and commercializing pharmaceutical and nutraceutical products that utilize distinctive bioactive marine compounds. One of their notable projects is HRO350, an innovative oral drug candidate aimed at treating mild-to-moderate psoriasis, addressing a significant patient demographic in need of effective and safe treatments. Products from Arctic Bioscience are globally marketed as both ingredients and finished goods under the ROMEGA brand, showcasing the company’s diverse portfolio and expertise.
Frequently Asked Questions
What is B-Romega™?
B-Romega™ is an innovative supplement derived from herring caviar oil, rich in phospholipid Omega-3, designed to support health across various life stages.
What health benefits does B-Romega™ provide?
B-Romega™ is known to support heart, brain, eye, and skin health through its superior absorption of Omega-3 phospholipids.
Who is Groupe Berkem?
Groupe Berkem is a leading organization in bio-based chemicals, promoting environmental transition and developing innovative solutions for various industries.
What does Arctic Bioscience specialize in?
Arctic Bioscience focuses on developing pharmaceuticals and nutraceuticals based on unique bioactive marine compounds, including their work on HRO350 for psoriasis treatment.
Where can I find more information about these companies?
For detailed information, visit the official websites of Groupe Berkem and Arctic Bioscience to explore their products and innovations.
